Skip to main content
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India flag India · Delayed Price · Currency is INR
1,638.60
-1.20 (-0.07%)
Aug 14, 2025, 3:30 PM IST

NSE:SUNPHARMA Revenue

Sun Pharmaceutical Industries had revenue of 138.51B INR in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 537.77B, up 9.28% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.

Revenue (ttm)
537.77B
Revenue Growth
+9.28%
P/S Ratio
7.32
Revenue / Employee
12.51M
Employees
43,000
Market Cap
3,934.43B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025525.78B40.82B8.42%
Mar 31, 2024484.97B46.11B10.51%
Mar 31, 2023438.86B52.31B13.53%
Mar 31, 2022386.54B51.56B15.39%
Mar 31, 2021334.98B6.61B2.01%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Divi's Laboratories 96.52B
Cipla 274.80B
Apollo Hospitals Enterprise 225.51B
Mankind Pharma 129.10B
Zydus Lifesciences 236.08B
Fortis Healthcare 80.94B
Aurobindo Pharma 320.25B
Alkem Laboratories 133.04B
Revenue Rankings

Sun Pharmaceutical Industries News

More News